Occurrence patterns of pharmaceuticals in water and wastewater environments
By A. Nikolaou, S. Meriç, D. Fatta. Analytical and Bioanalytical Chemistry, 2007
926 citations recorded by the source corpus.
Subfields: Analytical Chemistry, Environmental Chemistry, Pollution
View Paper: https://www.semanticscholar.org/paper/21a5ce061a24a26e83c7cf7becab10b8a1c5c930
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pollution
Citations in the corpus
- Contamination of surface, ground, and drinking water from pharmaceutical production (2009, background): “Low nanograms per liter up to a few micrograms per liter of more than 150 active pharmaceutical ingredients (APIs) have been detected in sewage effluents and surface waters, mainly as a result of excretion with urine and feces and to some extent from inappropriate disposal of unused drugs [1–6].”
- Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment (2017, neutral): “pharmaceuticals can also reach freshwater through run-off from land treated with digested sludge for agricultural purposes [119].”
- Photocatalytic degradation of paracetamol on TiO 2 nanoparticles and TiO 2 /cellulosic fiber under UV and sunlight irradiation (2017, background): “The presence of trace paracetamol and other xenobiotic compounds in drinking water is also of public concern since little is known about potential chronic health effects associated with long-term ingestion of these compounds through drinking water (Nikolaou et al., 2007; Ikehata et al., 2006).”
- Review of risk from potential emerging contaminants in UK groundwater. (2012, background): “A wide range of pharmaceutical products have been detected in surface and groundwater, associated with wastewater disposal (Barnes et al., 2008; Miller and Meek, 2006; Nikolaou et al., 2007; Pérez and Barceló, 2007; Ternes and Hirsch, 2000; Vulliet and Cren-Olivé, 2011; Watkinson et al., 2009).”
- Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. (2009, background): “(2007), Pérez and Barceló (2007b), Canonica et al.”